Navigation Links
BD Biosciences to Distribute FCS Express
Date:1/26/2009

LOS ANGELES, Jan. 26 /PRNewswire/ -- De Novo Software(TM), a leading provider of flow cytometry data analysis solutions, announced today an agreement with BD Biosciences to sell De Novo Software's flagship product -- FCS Express(TM) -- to customers in clinical, research and pharmaceutical markets worldwide. BD Biosciences, a segment of BD (Becton, Dickinson and Company) is a pioneer and leader in flow cytometry systems and reagents.

"We look forward to providing BD customers with enhanced flow cytometry data analysis capabilities," said De Novo Software President David Novo. "BD Biosciences and De Novo Software will work together to ensure our customers have a positive support experience and build on the existing BD FACSDiva(TM) software integration capabilities present in FCS Express."

Used today by many leading clinical and research laboratories, FCS Express provides comprehensive analysis capabilities, including advanced and easy-to-use report creation tools, 21 CFR Part 11 data security support, quality control alerts and histogram overlays.

"BD Biosciences is committed to offering comprehensive, innovative solutions to support the work of researchers and clinicians in their efforts to understand disease and improve care," said Andy Last, Vice President, Global Marketing and Strategic Planning, BD Biosciences. "FCS Express is the industry's only third-party analysis software for flow cytometry that is registered with the FDA for IVD use. It meets clinical customer requirements and adds new capabilities that complement BD FACSDiva(TM) software."

Customers will be able to purchase FCS Express through the BD Biosciences sales force, website and catalog.

For more information, please visit www.denovosoftware.com or www.bdbiosciences.com

    Contact Information:
    David Novo                        Jim Harper
    President                         Software Product Manager
    De Novo Software                  BD Biosciences
    info@denovosoftware.com           jim_harper@bd.com
    213.814.1240                      408.954.2561

About De Novo Software

De Novo Software provides integrated solutions for the life sciences, primarily in the field of flow cytometry data analysis. Its primary product, FCS Express, is used by over one thousand laboratories worldwide for research purposes, and dozens of clinical laboratories for high throughput clinical analysis. As the only third-party flow analysis software registered with the FDA for in-vitro diagnostic use, FCS Express is the analysis tool of choice for the clinical laboratory. In addition, De Novo Software has extensive experience creating custom data analysis solutions and integrating with large scale LIS and HIS systems. For more information, please visit www.denovosoftware.com.


'/>"/>
SOURCE De Novo Software
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. MichBio Will Publish 2009 Michigan Biosciences Directory and Resource Guide
2. Cell Biosciences Introduces Kits for Oncoprotein Analysis
3. Dr. Steven L. Zelenkofske Joins Regado Biosciences as Senior Vice President, Clinical and Medical Affairs and Chief Medical Officer
4. Cyntellect Appoints Former Millipore and BD Biosciences Executives to Head Up its Product Marketing Efforts
5. Sigma-Aldrich and Sangamo BioSciences Announce the Achievement of Key Throughput Milestone in Research Reagents Agreement
6. Alliance Biosciences Announces Trade Mission to Singapore with Speaker Presentation at International Lab Design Seminar
7. Cell Biosciences Delivers Next Generation System to Stanford University
8. Regado Biosciences To Present at the 27th Annual J.P. Morgan Healthcare Conference
9. YM BIOSCIENCES RECEIVES CLEARANCE TO INITIATE RANDOMIZED DOUBLE-BLIND CLINICAL TRIALS OF NIMOTUZUMAB IN LUNG CANCER AND BRAIN METASTASES FROM LUNG CANCER
10. Sangamo BioSciences to Present at the 27th Annual J.P. Morgan Healthcare Conference
11. YM BIOSCIENCES NIMOTUZUMAB SELECTED FOR MULTINATIONAL PHASE III TRIAL BY NATIONAL CANCER CENTRE OF SINGAPORE
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2017)... ... May 23, 2017 , ... Kathy Goin is ... Clinical Operations. She brings years of expertise in establishing and leading clinical operations ... as a licensed occupational therapist, through a variety of leadership roles in Clinical ...
(Date:5/22/2017)... ... May 22, 2017 , ... ... leaders of the Maryland Biohealth community in developing and issuing recommendations to grow ... U.S. BioHealth Innovation Hub by 2023. , The recommendations are ...
(Date:5/19/2017)... ... May 19, 2017 , ... The ... Academic researchers with technologies ripe for commercialization, and who are affiliated with the ... encouraged to submit proposals. QED, now in its tenth round, is the first ...
(Date:5/18/2017)... , ... May 17, 2017 ... ... standards with psychonneuroendocrine stress expertise, and further enhances its scientific power by ... Douglas A. Granger, Ph.D., has agreed to join the scientific advisory board. ...
Breaking Biology Technology:
(Date:3/30/2017)... , March 30, 2017  On April 6-7, ... Hack the Genome hackathon at Microsoft,s headquarters ... two-day competition will focus on developing health and wellness ... Hack the Genome is the first ... tremendous. The world,s largest companies in the genomics, tech ...
(Date:3/30/2017)... , March 30, 2017 Trends, opportunities ... (physiological and behavioral), by technology (fingerprint, AFIS, iris recognition, ... recognition, and others), by end use industry (government and ... immigration, financial and banking, and others), and by region ... , Asia Pacific , and ...
(Date:3/28/2017)... , March 28, 2017 The ... Hardware (Camera, Monitors, Servers, Storage Devices), Software (Video Analytics, ... Region - Global Forecast to 2022", published by MarketsandMarkets, ... 2016 and is projected to reach USD 75.64 Billion ... and 2022. The base year considered for the study ...
Breaking Biology News(10 mins):